new glp-1 weight loss oral drug delivers up to 12% in 36 weeks How GLP-1 medications are transforming

On days when you feel more like eating, add a small piece of whole grain toast

TSA officers may swab your medication or case for explosive residue routine

By stimulating these two hormone pathways simultaneously, tirzepatide regulates appetite, slows gastric emptying, improves insulin sensitivity, and promotes fat mobilization, producing greater, more sustained weight loss than GLP-1-only therapies like semaglutide

"This is the first clinical trial to demonstrate that semaglutide may improve liver fibrosis in patients with advanced MASH, including those with compensated cirrhosis," said Rohit Loomba, MD, senior author of the study, gastroenterologist and hepatologist at UC San Diego Health and chief of the Division of Gastroenterology and Hepatology at UC San Diego School of Medicine

FASEB J 26(6):23832393